Assyro AI
FDA 483 Database

FDA Form 483s Issued in August 2022

Every published Form FDA 483 issued in August 2022, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

17

Published 483s in August 2022

17

Distinct firms

Form 483s issued in August 2022

Biocon Sdn. Bhd.FDA
FEI
3011248248
Issued
Aug 30, 2022
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
Malaysia
Vetter Pharma-Fertigung GmbH & Co. KGFDA
FEI
3005987757
Issued
Aug 26, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
Germany
iRhythm TechnologiesFDA
FEI
3021769057
Issued
Aug 12, 2022
Establishment
Medical Device Manufacturer
Location
California, United States
QuVa Pharma, Inc.FDA
FEI
3012053582
Issued
Aug 18, 2022
Establishment
Outsourcing Facility
Location
Texas, United States
Carolina InfusionFDA
FEI
3015826782
Issued
Aug 12, 2022
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
South Carolina, United States
Infusion Systems of SW Florida Inc. dba Myerlee PharmacyFDA
FEI
3011123993
Issued
Aug 11, 2022
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Florida, United States
Auro Pharmacies, Inc.FDA
FEI
3011893599
Issued
Aug 12, 2022
Establishment
Compounding Pharmacy
Location
California, United States
ImprimisRx NJFDA
FEI
3003348498
Issued
Aug 5, 2022
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
New Jersey, United States
Jubilant Generics Ltd.FDA
FEI
300689582
Issued
Aug 1, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Catalent Belgium SAFDA
FEI
3007647000
Issued
Aug 19, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
Belgium
ImClone Systems, LLCFDA
FEI
3002889358
Issued
Aug 25, 2022
Establishment
Drug Manufacturer
Location
New Jersey, United States
Empower Clinic Services LLC dba Empower PharmacyFDA
FEI
3011887629
Issued
Aug 5, 2022
Establishment
Outsourcing Facility
Location
Texas, United States
Biocon Biologics LimitedFDA
FEI
3015283245
Issued
Aug 26, 2022
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
India
Biocon Biologics LimitedFDA
FEI
3003981475
Issued
Aug 26, 2022
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
India
Cipla LimitedFDA
FEI
3004081307
Issued
Aug 26, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Aurobindo Pharma LimitedFDA
FEI
3004611182
Issued
Aug 2, 2022
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
India
Sun Pharmaceuticals Industries LimitedFDA
FEI
3002807979
Issued
Aug 12, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
India

Other months in 2022

Back to the FDA 483 Database